Pheochromocytoma unmasked by imipramine in an 8-year-old girl

Pediatric Emergency Care

Volumn 19, Issue 3, 2003, Pages 174-177

  Brown, Kathleen ^a,b   Ratner, Michael ^a   Stoll, Mathew ^b  

^a Department of Emergency Medicine ^*  (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Cardiomyopathy; Enuresis; Hypertension; Pheochromocytoma; Tricyclic antidepressants

Indexed keywords

CATECHOLAMINE; IMIPRAMINE; LABETALOL; NITROPRUSSIDE SODIUM; PHENOXYBENZAMINE; PHENTOLAMINE;

ABDOMINAL PAIN; ANAMNESIS; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAPHORESIS; DISEASE COURSE; ENURESIS; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; SCHOOL CHILD; SYMPTOMATOLOGY; TACHYCARDIA; TREATMENT PLANNING; URINE CULTURE;

EID: 0038376298     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000081243.98249.e9     Document Type: Article

References (31)

1. Hermann H, Mornex R. Human Tumours Secreting Catecholamines: Clinical and Physiopathological Study of the Pheochromocytomas. New York, NY: Pergamon Press; 1964.
2. Minno A, Bennett W, Kvale W. Pheochromocytoma: a study of 15 cases diagnosed at necropsy. Proc Staff Meet Mayo Clin. 1955;30:394-396.
3. Mok J, Swann I. Diagnosis of phaeochromocytoma after ingestion of imipramine. Arch Dis Child. 1978;53:676-677.
4. Birkebaek NH, Perrild BD. Pheochromocytoma diagnosed in an enuretic boy after imipramine-induced hypertension. Pediatr Hematol Oncol. 1986;3:283-285.
5. Kaufmann JS. Letter: Pheochromocytoma and tricyclic antidepressants. JAMA. 1974;229:1282.
6. Johnson ER, Jones MD, Stewart JN. Occurrence of a pheochromocytoma after ingestion of imipramine. J Am Osteopath Assoc. 1979;78: 332-335.
7. Achong MR, Keane PM. Pheochromocytoma unmasked by desipramine therapy. Ann Intern Med. 1981;94:358-359.
8. Ferguson KL. Imipramine-provoked paradoxical pheochromocytoma crisis: a case of cardiogenic shock. Am J Emerg Med. 1994;12:190-192.
9. Korzets A, Floro S, Ori Y, et al. Clomipramine-induced pheochromocytoma crisis: a near fatal complication of a tricyclic antidepressant. J Clin Psychopharmacol. 1997;17:428-430.
10. Kuhs H. Unmasking pheochromocytoma by amitriptyline [in German], Nervenarzt. 1998;69:76-77.
11. Cook RF, Katritsis D. Hypertensive crisis precipitated by a monoamine oxidase inhibitor in a patient with phaeochromocytoma [letter]. BMJ. 1990;300:614.
12. Axelrod J, Whitby L, Hertting G. Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science. 1961;133:383-384.
13. Maas JW. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry. 1975;32:1357-1361.
14. Schaffer MS, Zuberbuhler P, Wilson G, et al. Catecholamine cardiomyopathy: an unusual presentation of pheochromocytoma in children. J Pediatr. 1981;99:276-279.
15. Serfas D, Shoback DM, Lorell BH. Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade. Lancet. 1983;2: 711-713.
16. Shub C, Cueto-Garcia L, Sheps SG, et al. Echocardiographic findings in pheochromocytoma. Am J Cardiol. 1986;57:971-975.
17. Imperato-McGinley J, Gautier T, et al. Reversibility of catecholamineinduced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med. 1987;316:793-797.
18. Sardesai SH, Mourant AJ, Sivathandon Y, et al. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990;63:234-237.
19. Quezado ZN, Keiser HR, Parker MM. Reversible myocardial depression after massive catecholamine release from a phaeochromocytoma. Crit Care Med. 1992;20:549-551.
20. Nanda AS, Feldman A, Liang CS. Acute reversal of pheochromocytomainduced catecholamine cardiomyopathy. Clin Cardiol. 1995;18:421-423.
21. Mootha VK, Feldman J, Mannting F, et al. Pheochromocytomainduced cardiomyopathy. Circulation. 2000;102:e11-e13.
22. Brilakis ES, Young WF, Wilson JW, et al. Reversible catecholamineinduced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension. J Heart Lung Transplant. 1999;18: 376-380.
23. Simmons M, Downing SE. Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J. 1985;109:297-304.
24. Bissada NK, Finkbeiner AE. Pharmacology of continence and micturition. Am Fam Physician. 1979;20:128-136.
25. 1-Adrenoceptors in urethral function. Eur Urol. 1999;36:74-79.
26. Gimpel GA, Warzak WJ, Kuhn BR, et al. Clinical perspectives in primary nocturnal enuresis. Clin Pediatr (Phila). 1998;37:23-29.
27. Cendron M. Primary nocturnal enuresis: current. Am Fam Physician. 1999;59:1205-1214, 1219-1220.
28. Rushton HG. Wetting and functional voiding disorders. Urol Clin North Am. 1995;22:75-93.
29. Fisher DA. Norepinephrine inhibition of vasopressin antidiuresis. J Clin Invest. 1968;47:540-547.
30. Klein LA. α-Adrenergic (norepinephrine) effect on antidiuretic hormone activity. Invest Urol. 1975;13:159-164.
31. Lang CC, Rahman AR, Balfour DJ, et al. Effect of noradrenaline on renal sodium and water handling in euhydrated and overhydrated man. Clin Sci (Lond). 1993;85:487-494.